Biotage AB (BIOT) — Strategic Asset Allocation Index
Biotage AB (BIOT) has a Strategic Asset Allocation Index of 7.9% as of March 2025. Strategic assets (PP&E of Skr302.00 Million plus long-term investments of Skr-) total Skr302.00 Million, measured against net assets of Skr3.85 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Biotage AB Strategic Asset Allocation Index (2000–2024)
This chart shows how Biotage AB's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2024. As of March 2025, the index stands at 7.9%, representing strategic assets of Skr302.00 Million against net assets of Skr3.85 Billion SEK. Explore BIOT cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Biotage AB (2000–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Biotage AB from 2000 to 2024, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Biotage AB (BIOT) market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 8.0% | Skr330.00 Million | Skr330.00 Million | Skr- | Skr4.11 Billion | ▲ +0.3 pp |
| 2023 | 7.8% | Skr284.00 Million | Skr284.00 Million | Skr- | Skr3.66 Billion | ▼ -2.1 pp |
| 2022 | 9.9% | Skr162.00 Million | Skr162.00 Million | Skr- | Skr1.64 Billion | ▲ +0.6 pp |
| 2021 | 9.3% | Skr128.00 Million | Skr128.00 Million | Skr- | Skr1.37 Billion | ▼ -1.2 pp |
| 2020 | 10.5% | Skr104.00 Million | Skr104.00 Million | Skr- | Skr990.04 Million | ▼ -4.2 pp |
| 2019 | 14.7% | Skr128.87 Million | Skr112.25 Million | Skr16.61 Million | Skr875.50 Million | ▲ +5.3 pp |
| 2018 | 9.4% | Skr66.00 Million | Skr48.63 Million | Skr17.37 Million | Skr702.18 Million | ▼ -1.0 pp |
| 2017 | 10.4% | Skr63.14 Million | Skr45.30 Million | Skr17.84 Million | Skr608.61 Million | ▼ -1.0 pp |
| 2016 | 11.4% | Skr64.09 Million | Skr45.45 Million | Skr18.64 Million | Skr563.24 Million | ▲ +3.2 pp |
| 2015 | 8.2% | Skr44.72 Million | Skr44.72 Million | Skr- | Skr546.66 Million | ▼ -0.4 pp |
| 2014 | 8.6% | Skr43.06 Million | Skr43.06 Million | Skr- | Skr502.65 Million | ▼ -0.2 pp |
| 2013 | 8.7% | Skr41.61 Million | Skr41.61 Million | Skr- | Skr476.77 Million | ▲ +1.1 pp |
| 2012 | 7.7% | Skr40.70 Million | Skr40.70 Million | Skr- | Skr530.83 Million | ▲ +0.7 pp |
| 2011 | 7.0% | Skr39.47 Million | Skr39.47 Million | Skr- | Skr563.90 Million | ▲ +0.8 pp |
| 2010 | 6.2% | Skr35.33 Million | Skr35.33 Million | Skr- | Skr567.95 Million | ▲ +2.4 pp |
| 2009 | 3.8% | Skr41.91 Million | Skr41.91 Million | Skr- | Skr1.09 Billion | ▼ -3.4 pp |
| 2008 | 7.2% | Skr80.98 Million | Skr80.98 Million | Skr- | Skr1.12 Billion | ▼ -3.5 pp |
| 2007 | 10.7% | Skr84.99 Million | Skr84.99 Million | Skr- | Skr796.26 Million | ▼ -2.7 pp |
| 2006 | 13.4% | Skr95.33 Million | Skr95.33 Million | Skr- | Skr712.47 Million | ▼ -2.0 pp |
| 2005 | 15.4% | Skr113.42 Million | Skr113.42 Million | Skr- | Skr738.25 Million | ▼ -1.7 pp |
| 2004 | 17.1% | Skr89.33 Million | Skr89.33 Million | Skr- | Skr523.13 Million | ▼ -0.6 pp |
| 2003 | 17.7% | Skr107.60 Million | Skr107.60 Million | Skr- | Skr609.50 Million | ▲ +9.3 pp |
| 2002 | 8.3% | Skr51.27 Million | Skr51.27 Million | Skr- | Skr616.16 Million | ▲ +1.3 pp |
| 2001 | 7.0% | Skr55.07 Million | Skr55.07 Million | Skr- | Skr784.98 Million | ▲ +3.0 pp |
| 2000 | 4.0% | Skr35.96 Million | Skr35.96 Million | Skr- | Skr902.36 Million | — |